Statistics

Total Visits

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study113

Select a period of time:

Number of views in the range

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study25

Views

Views
November 20255
December 20254
January 20261
February 20260
March 202611
April 20264
May 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States15
Germany2
Brazil1
Chile1
Colombia1
Ecuador1
United Kingdom1
Panama1
Puerto Rico1
Uruguay1
 

Top cities views

Views
San Jose5
Frankfurt am Main2
Ashburn1
Bogotá1
Canovanas1
Guayaquil1
Hampton1
Montevideo1
Panama City1
Porto Alegre1